Top compounds associated with response to SLC16A9


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC -0.02 0.7
mRNA lapatinib UHNBreast pan-cancer AAC 0.11 0.7
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.013 0.7
mRNA GW843682X GDSC1000 pan-cancer AAC -0.018 0.7
mRNA Sorafenib CCLE pan-cancer AAC 0.017 0.7
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.016 0.7
mRNA CIL55 CTRPv2 pan-cancer AAC 0.021 0.7
mRNA FH535 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA Topotecan CCLE pan-cancer AAC 0.015 0.7
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.012 0.7
Download CSV